However, antibody-mediated inhibition of CTLA-4 and PD-1 aggravated T cell–driven inflammation in atherosclerotic plaques of hyperlipidemic mice and provoked the progression of atherosclerosis toward a clinically unfavorable plaque phenotype. The gene discussed is CTLA4; the disease is atherosclerosis.